Rajatesh Gudibande

Mission oriented leader driving growth and technological disruption for groundbreaking medical technology venture in chronic disease management and prevention. Pioneered commercialization of world’s first needle-free continuous glucose monitoring (CGM) system from concept to clinical trials for FDA approval for diabetes management. Architected product roadmaps and corporate strategy driving >10X value growth. Built and led cross-functional teams of over 30 engineers, scientists, and regulatory experts through the entire product lifecycle - from R&D and prototyping to clinical validations, regulatory strategy, and manufacturing ramp-ups. Fostered a culture of relentless innovation and execution. Instrumental in strategic alliances, board governance, and investor relations. Combines technological excellence with business acumen and entrepreneurial mindset to bring cutting-edge solutions envisioning humanity as a Type 1 civilization. Recognized thought leader on democratizing preventative healthcare through innovation.

• San Francisco, California

• Senior Product Development Manager, Graphene Frontiers
• Graduate Research Assistant, UPenn Nanophysics Lab (Charlie Johnson Group)

• U.S. Patent US9930777B2 (granted) | Japan Patent (JPO) JP7329305B2 (granted) | CNIPA CN107073518B (granted), Scalable, printable, patterned sheet of high mobility graphene on flexible substrates.
• U.S. Patent application US20190257732A1 | Japan Patent (JPO) JP7129405B2 (granted) | CNIPA 109642888B (granted), Polar fluid gated field effect device.
• U.S. Patent application US20210212603A1 | Japan Patent (JPO) JP7402391B2 (granted), Replaceable sensor systems and methods

• Fierce Life Science Innovation Awards 2022
• Digital Health Awards 2022, University of California San Francisco (UCSF), San Francisco, CA.
• Select committee for Pluralism and International Affairs, Graduate and Professional Student Assembly (GAPSA), University of Pennsylvania, 2014.

• Invited on Bleeding Edge of Digital Health Podcast with Mike Moore, to discuss Needle-Free CGM, the Holy Grail of Diabetes, 2023.
• Invited on MedTech Gurus Podcast- Having a Mindset to Scale to share insights on problem solving, product development and innovations in healthcare, 2022
• Invited on Empowered Patient Podcast with Karen Jagoda to discuss Tasting Molecules on the Skin with Smart Needle-Free Device to Monitor and Diagnose Chronic Conditions and Infectious Diseases, 2022.
• Invited talk, Clare Foundation STEM Speakers Series, Episcopal Academy, Newtown Square, PA, 2022.
• Invited panel discussion, MedTech Innovator, Always-On Remote Monitoring Showcase, San Francisco, 2021.
• Invited presentation at Leaders forum, Health Tech showcase, American Diabetes Association (ADA), San Francisco 2020.

• Board Member & Advisor, GraphWear Technologies Inc.
• Mentored founders of innovative healthcare and technology startups (E-Nano, Ne-VAp, Safe BVM, Instahub)
• Startup mentor for healthcare and technology ventures at Nasdaq Entrepreneurial Center

• Business Insider top 100 people transforming business in 2023
• Fast Company, MedTech Innovator Top 50
• Winner of numerous startup programs (JLABS, Pfizer, Plug and Play, Medtech etc.)

• Electronic transport in heterostructures of chemical vapor deposited graphene and hexagonal boron nitride ZJ Qi, SJ Hong, JA Rodríguez‐Manzo, NJ Kybert, R Gudibande, M Drndić, ... Small 11 (12), 1402-1408.
• Sensorless control of brushless DC motor using adaptive neuro fuzzy inference algorithm P Devendra, G Rajatesh, KA Mary, C Saibabu, 2011 IEEE International Conference on Energy, Automation and Signal, 1-5.
• Differentiating human cervical dysplastic and normal tissue through wavelet domain characterization of intrinsic fluorescence R Gudibande, M Mozumder, R Singh, PK Panigrahi, S Gupta, A Pradhan, Proc. SPIE 7902, Imaging, Manipulation, and Analysis of Biomolecules, Cells, and Tissues IX.